Hangzhou Sumgen Biotech Co., Ltd.

This early-stage study is testing a new drug called SG2918 in patients whose multiple myeloma has returned or stopped responding to other treatments. The main goal is to check if the drug is safe and what side effects it causes in about 40 participants. Researchers will also look…

This study is testing whether a new injectable drug called SG301 can help control the symptoms and disease activity of systemic lupus erythematosus (SLE). It will involve about 120 adults with moderate-to-severe lupus who haven't responded well to standard treatments. Participant…